Cytosorbents Corporation - Company Information
Cytosorbents corporation (nasdaq: ctso) is a new jersey-based company involved in the r&d and commercialization of medical devices using its proprietary polymer adsorption technology. cytosorbents is a leader in the treatment of life-threatening conditions in the icu and cardiac surgery using blood purification. its flagship product, cytosorb®, is distributed in more than 70 countries and has ce mark approval in the eu for cytokine, bilirubin and myoglobin removal in numerous critical care applications and the removal of ticagrelor and rivaroxaban during cardiothoracic surgery. cytosorbents has multiple active, clinical trials ongoing, including two pivotal randomized, controlled trials in the united states designed to support eventual fda marketing approval for antithrombotic removal during cardiothoracic surgery using the drugsorb™-atr antithrombotic removal system.
Medical Devices
Cytosorbents Corporation - Technology Stack
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by Sprouts.ai, used by Cytosorbents Corporation.
Materialize
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Javascript
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Vue.js
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
TweenMax
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Polyfill
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
PHP
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Employee profile
John Doe
CEO
Samantha Duncan
CTO
Gary Austin
MD
Jonathan Shaw
CMD
Janice May
MD
Janet McDonald
CFO
Cytosorbents Corporation - Company Information
Cytosorbents corporation (nasdaq: ctso) is a new jersey-based company involved in the r&d and commercialization of medical devices using its proprietary polymer adsorption technology. cytosorbents is a leader in the treatment of life-threatening conditions in the icu and cardiac surgery using blood purification. its flagship product, cytosorb®, is distributed in more than 70 countries and has ce mark approval in the eu for cytokine, bilirubin and myoglobin removal in numerous critical care applications and the removal of ticagrelor and rivaroxaban during cardiothoracic surgery. cytosorbents has multiple active, clinical trials ongoing, including two pivotal randomized, controlled trials in the united states designed to support eventual fda marketing approval for antithrombotic removal during cardiothoracic surgery using the drugsorb™-atr antithrombotic removal system.
Medical Devices
Cytosorbents Corporation - Technology Stack
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by Sprouts.ai, used by Cytosorbents Corporation.
Materialize
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Javascript
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Vue.js
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
TweenMax
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Polyfill
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
PHP
Some quick example text to build on the card title and make up the bulk of the card&aposs content.
Employee profile
John Doe
CEO
Samantha Duncan
CTO
Gary Austin
MD
Jonathan Shaw
CMD
Janice May
MD
Janet McDonald
CFO
